{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:24:58Z","timestamp":1794489898873,"version":"4.9.1"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014943","name":"Sarepta Therapeutics Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014943","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007919","name":"University of Massachusetts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007919","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.omtn.2025.102685","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T07:34:45Z","timestamp":1755243285000},"page":"102685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular properties and intramolecular interactions of peptide-conjugated phosphorodiamidate morpholino oligonucleotides"],"prefix":"10.1016","volume":"36","author":[{"given":"Evgenii","family":"Kliuchnikov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farkhad","family":"Maksudov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pierson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arani","family":"Chanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1994-3917","authenticated-orcid":false,"given":"Valeri","family":"Barsegov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2025.102685_bib1","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/nar\/gkad067","article-title":"Chemistry, structure and function of approved oligonucleotide therapeutics","volume":"51","author":"Egli","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102685_bib2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2025.102685_bib3","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","article-title":"The current landscape of nucleic acid therapeutics","volume":"16","author":"Kulkarni","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omtn.2025.102685_bib4","doi-asserted-by":"crossref","first-page":"18188","DOI":"10.1074\/jbc.271.30.18188","article-title":"Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent","volume":"271","author":"Derossi","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtn.2025.102685_bib5","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1021\/ar2002304","article-title":"Peptide vectors for the nonviral delivery of nucleic acids","volume":"45","author":"Hoyer","year":"2012","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.omtn.2025.102685_bib6","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s12033-023-00679-1","article-title":"Application of cell penetrating peptides as a Promising drug carrier to combat viral infections","volume":"65","author":"Khairkhah","year":"2023","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.omtn.2025.102685_bib7","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.3390\/cancers14225546","article-title":"Cell-penetrating peptides (CPPs) as therapeutic and diagnostic agents for cancer","volume":"14","author":"Bottens","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omtn.2025.102685_bib8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.addr.2016.06.008","article-title":"Peptides for nucleic acid delivery","volume":"106","author":"Lehto","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2025.102685_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/oli.1.1997.7.187","article-title":"Morpholino antisense oligomers: design, preparation, and properties","volume":"7","author":"Summerton","year":"1997","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"10.1016\/j.omtn.2025.102685_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/108729003764097322","article-title":"HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers","volume":"13","author":"Moulton","year":"2003","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"10.1016\/j.omtn.2025.102685_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ab.2018.07.006","article-title":"Detection of unique Ebola virus oligonucleotides using fluorescently-labeled phosphorodiamidate morpholino oligonucleotide probe pairs","volume":"557","author":"Xiong","year":"2018","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.omtn.2025.102685_bib12","series-title":"Drug Approval Package: Exondys 51 Injection (eteplirsen)","first-page":"836","year":"2016"},{"key":"10.1016\/j.omtn.2025.102685_bib13","unstructured":"FDA. Drug Approval Package: Vyondys 53 (golodirsen). Published online 2019."},{"key":"10.1016\/j.omtn.2025.102685_bib14","unstructured":"FDA. Drug Approval Package: AMONDYS 45. Published online 2021."},{"key":"10.1016\/j.omtn.2025.102685_bib15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1021\/bc034221g","article-title":"Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides","volume":"15","author":"Moulton","year":"2004","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omtn.2025.102685_bib16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jconrel.2006.09.011","article-title":"Vectorization of morpholino oligomers by the (R-Ahx-R) 4 peptide allows efficient splicing correction in the absence of endosomolytic agents","volume":"116","author":"Abes","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2025.102685_bib17","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3390\/molecules14031304","article-title":"Gene knockdowns in adult animals: PPMOs and vivo-morpholinos","volume":"14","author":"Moulton","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.omtn.2025.102685_bib18","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.bbamem.2010.02.012","article-title":"Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy","volume":"1798","author":"Moulton","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtn.2025.102685_bib19","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1038\/mtna.2012.30","article-title":"Pip6-PMO, a new generation of peptide-oligonucleotide conjugates with improved cardiac exon skipping activity for DMD treatment","volume":"1","author":"Betts","year":"2012","journal-title":"Mol Ther Acids"},{"key":"10.1016\/j.omtn.2025.102685_bib20","article-title":"PPMO-mediated exon skipping induces uniform sarcolemmal dystrophin rescue with dose-dependent restoration of circulating microRNA biomarkers and muscle biophysical properties","author":"Chwalenia","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2025.102685_bib21","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3390\/cells12192395","article-title":"Enhancing Antisense Oligonucleotide-Based Therapeutic Delivery with DG9, a Versatile Cell-Penetrating Peptide","volume":"12","author":"Haque","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.omtn.2025.102685_bib22","doi-asserted-by":"crossref","first-page":"6837","DOI":"10.1093\/nar\/gki991","article-title":"Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells","volume":"33","author":"Turner","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102685_bib23","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3390\/pharmaceutics15030778","article-title":"Recent trends in antisense therapies for Duchenne muscular dystrophy","volume":"15","author":"Wilton-Clark","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2025.102685_bib24","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1021\/bc0501045","article-title":"Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity","volume":"16","author":"Nelson","year":"2005","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omtn.2025.102685_bib25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.omtn.2022.10.025","article-title":"Systemic PPMO-mediated dystrophin expression in the Dup2 mouse model of Duchenne muscular dystrophy","volume":"30","author":"Gushchina","year":"2022","journal-title":"Mol. Ther. Acids"},{"key":"10.1016\/j.omtn.2025.102685_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.omtn.2022.08.019","article-title":"A cell-penetrating peptide enhances delivery and efficacy of phosphorodiamidate morpholino oligomers in mdx mice","volume":"30","author":"Gan","year":"2022","journal-title":"Mol. Ther. Acids"},{"key":"10.1016\/j.omtn.2025.102685_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0167-4781(99)00150-5","article-title":"Morpholino antisense oligomers: the case for an RNase H-independent structural type","volume":"1489","author":"Summerton","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtn.2025.102685_bib28","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ebiom.2019.06.036","article-title":"Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases","volume":"45","author":"Tsoumpra","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omtn.2025.102685_bib29","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s11095-021-03118-5","article-title":"Pharmacokinetic\/pharmacodynamic modeling of a cell-penetrating peptide phosphorodiamidate morpholino oligomer in mdx mice","volume":"38","author":"Mukashyaka","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.omtn.2025.102685_bib30","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1080\/17425255.2021.1992382","article-title":"Antisense oligonucleotides: absorption, distribution, metabolism, and excretion","volume":"17","author":"Shadid","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.omtn.2025.102685_bib31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/bc060138s","article-title":"Stability of cell-penetrating peptide- morpholino oligomer conjugates in human serum and in cells","volume":"18","author":"Youngblood","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omtn.2025.102685_bib32","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.chembiol.2011.06.006","article-title":"Preferential uptake of L-versus D-amino acid cell-penetrating peptides in a cell type-dependent manner","volume":"18","author":"Verdurmen","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.omtn.2025.102685_bib33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1021\/acscentsci.0c01603","article-title":"Cytosolic Delivery of Argininosuccinate Synthetase Using a Cell-Permeant Miniature Protein","volume":"7","author":"Knox","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.omtn.2025.102685_bib34","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1021\/acs.biochem.9b00413","article-title":"Chimeras of cell-penetrating peptides demonstrate synergistic improvement in antisense efficacy","volume":"58","author":"Fadzen","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.omtn.2025.102685_bib35","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s41557-021-00766-3","article-title":"Deep learning to design nuclear-targeting abiotic miniproteins","volume":"13","author":"Schissel","year":"2021","journal-title":"Nat. Chem."},{"key":"10.1016\/j.omtn.2025.102685_bib36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1021\/acsbiomedchemau.1c00053","article-title":"Cell-penetrating d-peptides retain antisense morpholino oligomer delivery activity","volume":"2","author":"Schissel","year":"2022","journal-title":"ACS Bio. Med. Chem. Au."},{"key":"10.1016\/j.omtn.2025.102685_bib37","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/mt.2009.38","article-title":"Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice","volume":"17","author":"Wu","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102685_bib38","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ymthe.2017.10.004","article-title":"Cyclic peptides to improve delivery and exon skipping of antisense oligonucleotides in a mouse model for duchenne muscular dystrophy","volume":"26","author":"Jirka","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102685_bib39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijpharm.2017.08.116","article-title":"Amphiphilic lipopeptide significantly enhances uptake of charge-neutral splice switching morpholino oligonucleotide in spinal muscular atrophy patient-derived fibroblasts","volume":"532","author":"Tajik-Ahmadabad","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.omtn.2025.102685_bib40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/polym9050177","article-title":"Evaluation of amphiphilic peptide modified antisense morpholino oligonucleotides in vitro and in dystrophic mdx mice","volume":"9","author":"Wang","year":"2017","journal-title":"Polymers"},{"key":"10.1016\/j.omtn.2025.102685_bib41","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.omtn.2023.02.007","article-title":"Therapeutic phosphorodiamidate morpholino oligonucleotides: Physical properties, solution structures, and folding thermodynamics","volume":"31","author":"Maksudov","year":"2023","journal-title":"Mol. Ther. Acids"},{"key":"10.1016\/j.omtn.2025.102685_bib42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1261\/rna.067678.118","article-title":"software for analysis of nucleic acid structures and trajectories","volume":"25","author":"Bottaro","year":"2019","journal-title":"RNA"},{"key":"10.1016\/j.omtn.2025.102685_bib43","series-title":"Parenteral Technology Manual: An Introduction to Formulation, Production and Quality Aspects of Parenteral Products","author":"Groves","year":"1989"},{"key":"10.1016\/j.omtn.2025.102685_bib44","first-page":"77","article-title":"Technical considerations in the development of prefilled syringes for protein products","volume":"9","author":"Overcashier","year":"2006","journal-title":"Am. Pharm. Rev."},{"key":"10.1016\/j.omtn.2025.102685_bib45","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/334364a0","article-title":"Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its implications for meiosis","volume":"334","author":"Sen","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2025.102685_bib46","series-title":"Nucleic Acids: Structures, Properties, and Functions","author":"Bloomfield","year":"2000"},{"key":"10.1016\/j.omtn.2025.102685_bib47","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3390\/polym8080279","article-title":"Rheological properties of DNA molecules in solution: molecular weight and entanglement influences","volume":"8","author":"Bravo-Anaya","year":"2016","journal-title":"Polymers"},{"key":"10.1016\/j.omtn.2025.102685_bib48","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1529\/biophysj.106.097782","article-title":"Refinement of the AMBER force field for nucleic acids: improving the description of \u03b1\/\u03b3 conformers","volume":"92","author":"P\u00e9rez","year":"2007","journal-title":"Biophys. J."},{"key":"10.1016\/j.omtn.2025.102685_bib49","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1021\/ct200162x","article-title":"Refinement of the Cornell et al. nucleic acids force field based on reference quantum chemical calculations of glycosidic torsion profiles","volume":"7","author":"Zgarbov\u00e1","year":"2011","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.omtn.2025.102685_bib50","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1021\/acs.jctc.5b00716","article-title":"Refinement of the sugar-phosphate backbone torsion beta for AMBER force fields improves the description of Z-and B-DNA","volume":"11","author":"Zgarbov\u00e1","year":"2015","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.omtn.2025.102685_bib51","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1021\/ja00124a002","article-title":"A second generation force field for the simulation of proteins, nucleic acids, and organic molecules","volume":"117","author":"Cornell","year":"1995","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.omtn.2025.102685_bib52","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1021\/acs.molpharmaceut.2c00092","article-title":"A Biopharmaceutical Perspective on Higher-Order Structure and Thermal Stability of mRNA Vaccines","volume":"19","author":"Kloczewiak","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.omtn.2025.102685_bib53","series-title":"The Theory of Polymer Dynamics","volume":"73","author":"Doi","year":"1988"},{"key":"10.1016\/j.omtn.2025.102685_bib54","doi-asserted-by":"crossref","DOI":"10.1063\/1.3050095","article-title":"Nonparametric density estimation and optimal bandwidth selection for protein unfolding and unbinding data","volume":"130","author":"Bura","year":"2009","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.omtn.2025.102685_bib55","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1021\/acs.chemrev.7b00427","article-title":"RNA structural dynamics as captured by molecular simulations: a comprehensive overview","volume":"118","author":"Sponer","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.omtn.2025.102685_bib56","doi-asserted-by":"crossref","first-page":"10571","DOI":"10.1021\/acs.jpcb.9b07148","article-title":"Structure and hybridization properties of glycine morpholine oligomers in complexes with DNA and RNA: Experimental and molecular dynamics studies","volume":"123","author":"Golyshev","year":"2019","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.omtn.2025.102685_bib57","article-title":"Characterization of tertiary folding of RNA by circular dichroism and urea","volume":"Chapter 11","author":"Sosnick","year":"2001","journal-title":"Curr. Protoc. Nucleic Acid Chem."},{"key":"10.1016\/j.omtn.2025.102685_bib58","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/bip.1981.360200702","article-title":"Sequence dependence of the circular dichroism of synthetic double-stranded RNAs","volume":"20","author":"Gray","year":"1981","journal-title":"Biopolymers"},{"key":"10.1016\/j.omtn.2025.102685_bib59","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00396-008-1902-2","article-title":"Determination of intrinsic viscosities of macromolecules and nanoparticles. Comparison of single-point and dilution procedures","volume":"286","author":"Pamies","year":"2008","journal-title":"Colloid Polym. Sci."},{"key":"10.1016\/j.omtn.2025.102685_bib60","series-title":"Biochemistry (Loose-Leaf)","author":"Berg","year":"2007"},{"key":"10.1016\/j.omtn.2025.102685_bib61","first-page":"265","article-title":"Effects of arginine in therapeutic protein formulations: a decade review and perspectives","volume":"6","author":"Ren","year":"2023","journal-title":"Antib. Ther."},{"key":"10.1016\/j.omtn.2025.102685_bib63","series-title":"Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages. U.S. Patent No. 5,185,444","author":"Summerton","year":"1993"},{"key":"10.1016\/j.omtn.2025.102685_bib64","series-title":"Oligonucleotide analogs having cationic intersubunit linkages. U.S. Patent No. 7,943,762","author":"Weler","year":"2011"},{"key":"10.1016\/j.omtn.2025.102685_bib65","series-title":"Synthesis of fmoc-protected morpholino monomers and their use in the synthesis of morpholino oligomer. U.S. Patent No. 12,012,427","author":"Sinha","year":"2024"},{"key":"10.1016\/j.omtn.2025.102685_bib66","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-1-61779-151-2_14","article-title":"Synthesis of Oligonucleotide--Peptide Conjugates for Biomedical and Technological Applications","author":"Avi\u00f1\u00f3","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2025.102685_bib67","volume":"2587","author":"Maruyama","year":"2022"},{"key":"10.1016\/j.omtn.2025.102685_bib68","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1021\/cr0502448","article-title":"Peptide conjugates of oligonucleotides: synthesis and applications","volume":"106","author":"Venkatesan","year":"2006","journal-title":"Chem. Rev."},{"key":"10.1016\/j.omtn.2025.102685_bib69","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1021\/bc0000334","article-title":"Preparation and applications of peptide- oligonucleotide conjugates","volume":"11","author":"Tung","year":"2000","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omtn.2025.102685_bib70","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1021\/acs.jcim.6b00773","article-title":"Probing the binding interactions between chemically modified siRNAs and human argonaute 2 using microsecond molecular dynamics simulations","volume":"57","author":"Harikrishna","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.omtn.2025.102685_bib71","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aar8521","article-title":"Conformational ensembles of RNA oligonucleotides from integrating NMR and molecular simulations","volume":"4","author":"Bottaro","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2025.102685_bib72","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1021\/ct400314y","article-title":"Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald","volume":"9","author":"Salomon-Ferrer","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.omtn.2025.102685_bib73","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: An N\u22c5 log (N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.omtn.2025.102685_bib74","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cpc.2012.09.022","article-title":"SPFP: Speed without compromise\u2014A mixed precision model for GPU accelerated molecular dynamics simulations","volume":"184","author":"Le Grand","year":"2013","journal-title":"Comput. Phys. Commun."},{"key":"10.1016\/j.omtn.2025.102685_bib75","unstructured":"Case, D.A., Belfon, K., Ben-Shalom, I., Brozell, S.R., Cerutti, D., Cheatham, T., Cruzeiro, V.W.D., Darden, T., Duke, R.E., Giambasu, G., et al. Amber 2020 Reference Manual. 2020. Published online 2020."},{"key":"10.1016\/j.omtn.2025.102685_bib76","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A","article-title":"Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO)","volume":"20","author":"Weiser","year":"1999","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.omtn.2025.102685_bib77","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.omtn.2025.102685_bib78","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/jcc.21787","article-title":"MDAnalysis: a toolkit for the analysis of molecular dynamics simulations","volume":"32","author":"Michaud-Agrawal","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.omtn.2025.102685_bib79","first-page":"105","article-title":"MDAnalysis: a Python package for the rapid analysis of molecular dynamics simulations","volume":"98","author":"Gowers","year":"2016","journal-title":"Proc. Python Sci. Conf."},{"key":"10.1016\/j.omtn.2025.102685_bib80","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.1093\/nar\/gku972","article-title":"The role of nucleobase interactions in RNA structure and dynamics","volume":"42","author":"Bottaro","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102685_bib81","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/bioinformatics\/btp016","article-title":"DichroCalc\u2014circular and linear dichroism online","volume":"25","author":"Bulheller","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2025.102685_bib82","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1039\/b615870f","article-title":"Circular and linear dichroism of proteins","volume":"9","author":"Bulheller","year":"2007","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.omtn.2025.102685_bib83","series-title":"Circular Dichroism and the Conformational Analysis of Biomolecules","first-page":"433","article-title":"Determination of the Conformation of Nucleic Acids by Electronic CD","author":"Johnson","year":"1996"},{"key":"10.1016\/j.omtn.2025.102685_bib84","doi-asserted-by":"crossref","first-page":"E3095-","DOI":"10.1073\/pnas.1500851112","article-title":"Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy","volume":"112","author":"Micsonai","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102685_bib85","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1021\/jacs.6b01837","article-title":"Combined molecular dynamics simulations and experimental studies of the structure and dynamics of poly-amido-saccharides","volume":"138","author":"Chin","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.omtn.2025.102685_bib86","article-title":"Adam: A method for stochastic optimization","author":"Kingma","year":"2014","journal-title":"arXiv"},{"key":"10.1016\/j.omtn.2025.102685_bib87","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.bpj.2011.06.046","article-title":"Prediction of hydrodynamic and other solution properties of rigid proteins from atomic-and residue-level models","volume":"101","author":"Ortega","year":"2011","journal-title":"Biophys. J."},{"key":"10.1016\/j.omtn.2025.102685_bib88","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1021\/acs.jpcb.7b05654","article-title":"Conformational flexibility and self-association of fibrinogen in concentrated solutions","volume":"121","author":"Zuev","year":"2017","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.omtn.2025.102685_bib89","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.omtn.2025.102685_bib90","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA. py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.omtn.2025.102685_bib91","series-title":"Statistical Mechanics","author":"McQuarrie","year":"2000"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125002392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125002392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:39:32Z","timestamp":1777322372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253125002392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2162253125002392"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102685","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular properties and intramolecular interactions of peptide-conjugated phosphorodiamidate morpholino oligonucleotides","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102685"}}